COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2
Clinical trial NCT05075538 · TERMINATED
Trial details
- NCT number
- NCT05075538
- Sponsor
- Jules Bordet Institute
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2024-01-08
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.